Preliminary data from CBD clinical trials ‘promising’

Dr. Stephanie McGrath is overseeing clinical trials using CBD to treat dogs with epilepsy and osteoarthritis. Photo: John Eisele/CSU Photography

Dr. Stephanie McGrath, a neurologist at Colorado State University’s James L. Voss Veterinary Teaching Hospital, has revealed initial findings from a groundbreaking study to assess the use of cannabidiol, or CBD, for dogs with epilepsy.

Based on her research, she found that 89 percent of dogs who received CBD in a clinical trial had a reduction in the frequency of seizures.

“Overall, what we found seems very promising,” she said.

Sixteen dogs were enrolled in the clinical trial. Nine dogs were treated with CBD, which has 0.3 percent or less of the psychoactive component of cannabis, THC; seven dogs in a control group were treated with a placebo. The compound is not considered marijuana and can be used for research purposes based

... read more at: https://cvmbs.source.colostate.edu/preliminary-data-from-cbd-clinical-trials-promising/

by